Divalproex Sodium Tablet, Extended Release
Product Images NDC 0904-6363

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 0904-6363). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

49bf56b6 A134 2d0d C783 0cb83b8d1b38 00

This is a label for a medication called Divalproex Sodium Extended-Release Tablets, which are to be taken once a day. It's a prescription-only medicine and the package contains 100 units. The manufacturer is not clear from the text.*

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

This text appears to be a table or chart showing the improvement in CPS rate (the frequency of seizures) among patients taking high dose and low dose Divalproex Sodium delayed-release tablets. The table shows a 50% reduction in seizures among 50% of patients taking the high dose version of the medication. However, without further context or information, it is difficult to fully understand the significance of these findings.*

FDA Label Image

Figure3 (Figure3)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.